Orlistat (Xenical®) Raloxifene (Evista®) Spironolactone (Aldactone®) Orlistat (Xenical®) Approved indication: Management of obesity in patients with a body mass index (BMI) > 30 kg/m2 or a BMI > 27 kg/m2 in the presence of other cardiovascular risk factors (e.g....
The assessment of gabapentin (Neurontin) included in this Letter was based on potentially misleading information, as reported by the manufacturer. U.S. litigation in 2009-2010 has revealed that Neurontin’s off-label promotion, which over a relatively short...
Erectile dysfunction is defined as the inability to develop and sustain an erection adequate for intercourse on at least 50% of attempts. It occurs commonly and the incidence increases with age1. What are the implications for...
Health professionals need rapid access to unbiased information about new drugs. We try to provide it at the Therapeutics Initiative (TI) but it’s not always possible. A case in point is the latest NSAID licenced for...